This is not the most recent version of the article. View current version (19 JAN 2011)

Intervention Protocol

Adjuvant chemotherapy and/or radiotherapy after surgery for uterine carcinosarcoma

  1. Keith Godfrey1,*,
  2. Ram Athavale1,
  3. Katherine Deane2

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 8 OCT 2008

DOI: 10.1002/14651858.CD006812

How to Cite

Godfrey K, Athavale R, Deane K. Adjuvant chemotherapy and/or radiotherapy after surgery for uterine carcinosarcoma (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006812. DOI: 10.1002/14651858.CD006812.

Author Information

  1. 1

    Queen Elizabeth Hospital, Northern Gynaecological Oncology Centre, Gateshead, Tyne & Wear, UK

  2. 2

    Newcastle University, Institute of Health & Society, Newcastle-upon-Tyne, UK

*Keith Godfrey, Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Sheriff Hill, Gateshead, Tyne & Wear, NE9 6SX, UK. keith.godfrey@ghnt.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 OCT 2008

SEARCH

This is not the most recent version of the article.View current version (19 Jan 2011)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the role of adjuvant radiotherapy and/or systemic chemotherapy in the management of uterine carcinosarcoma.

Specifically we would wish to address the following questions.

  • Is adjuvant radiotherapy and/or systemic chemotherapy more effective than surgery alone in improving survival?
  • Is adjuvant radiotherapy and/or systemic chemotherapy more effective than surgery alone in delaying recurrence?
  • Is adjuvant radiotherapy and/or systemic chemotherapy acceptable?